[1]
K. Rothe, “Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients”, Multidiscip Respir Med, vol. 16, Oct. 2021, doi: 10.4081/mrm.2021.793.